[go: up one dir, main page]

NO20020222D0 - Oralt aktive androgener - Google Patents

Oralt aktive androgener

Info

Publication number
NO20020222D0
NO20020222D0 NO20020222A NO20020222A NO20020222D0 NO 20020222 D0 NO20020222 D0 NO 20020222D0 NO 20020222 A NO20020222 A NO 20020222A NO 20020222 A NO20020222 A NO 20020222A NO 20020222 D0 NO20020222 D0 NO 20020222D0
Authority
NO
Norway
Prior art keywords
orally active
active androgens
androgens
orally
active
Prior art date
Application number
NO20020222A
Other languages
English (en)
Other versions
NO20020222L (no
Inventor
Hubert Jan Jozef Loozen
Dirk Leysen
Jaap Van Der Louw
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20020222D0 publication Critical patent/NO20020222D0/no
Publication of NO20020222L publication Critical patent/NO20020222L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20020222A 1999-07-16 2002-01-15 Oralt aktive androgener NO20020222L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99202348 1999-07-16
PCT/EP2000/006544 WO2001005806A1 (en) 1999-07-16 2000-07-10 Orally active androgens

Publications (2)

Publication Number Publication Date
NO20020222D0 true NO20020222D0 (no) 2002-01-15
NO20020222L NO20020222L (no) 2002-01-25

Family

ID=8240463

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020222A NO20020222L (no) 1999-07-16 2002-01-15 Oralt aktive androgener

Country Status (28)

Country Link
US (3) US6313108B1 (no)
EP (1) EP1203011B1 (no)
JP (1) JP2003505394A (no)
KR (1) KR20020092890A (no)
CN (1) CN1360589A (no)
AR (1) AR024746A1 (no)
AT (1) ATE257159T1 (no)
AU (1) AU770412B2 (no)
BR (1) BR0012489A (no)
CA (1) CA2379223A1 (no)
CO (1) CO5200765A1 (no)
CZ (1) CZ2002192A3 (no)
DE (1) DE60007530T2 (no)
ES (1) ES2213596T3 (no)
HK (1) HK1043797A1 (no)
HU (1) HUP0201952A3 (no)
IL (1) IL147332A0 (no)
MX (1) MXPA02000601A (no)
NO (1) NO20020222L (no)
NZ (1) NZ516525A (no)
PE (1) PE20010330A1 (no)
PL (1) PL353007A1 (no)
RU (1) RU2002103883A (no)
SK (1) SK712002A3 (no)
TR (1) TR200200076T2 (no)
TW (1) TW548277B (no)
WO (1) WO2001005806A1 (no)
ZA (1) ZA200200106B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002541153A (ja) * 1999-04-06 2002-12-03 アクゾ・ノベル・エヌ・ベー 経口活性アンドロゲン
US20030069215A1 (en) * 2001-03-30 2003-04-10 The Government Of The United States Of America, Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate
WO2001074839A2 (en) * 2000-03-31 2001-10-11 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use
WO2003045398A1 (en) * 2001-03-30 2003-06-05 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods of making and pharmaceutical formulations comprising 7alpha, 11beta-dimethy-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof
ES2241854T3 (es) * 2000-07-28 2005-11-01 Akzo Nobel N.V. Estrogenos de sustitucion metilo o etilo en posicion 16 alfa.
BRPI0306736B8 (pt) * 2002-01-21 2021-05-25 Akzo Nobel Nv processo para a preparação de 7alfa-metilesteróides, e, composto
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
WO2010043404A1 (en) * 2008-10-15 2010-04-22 Synthon B.V. Processes and intermediates for the production of fulvestrant
SG195121A1 (en) * 2011-06-01 2013-12-30 Estetra S A Process for the production of estetrol intermediates
AU2012264602B2 (en) 2011-06-01 2017-03-09 Estetra Srl Process for the production of estetrol intermediates
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
PT2764008T (pt) * 2011-10-07 2016-11-10 Estetra Sprl Processo para a produção de estetrol
WO2015181116A1 (en) 2014-05-26 2015-12-03 Crystal Pharma, S.A.U. Process and intermediades for the preparation of 7-alkylated steroids
SI3310345T1 (sl) 2015-06-18 2021-05-31 Estetra Sprl Orodisperzibilna tableta, ki vsebuje estetrol
SMT202200102T1 (it) 2015-06-18 2022-05-12 Estetra Srl Unità di dosaggio orodispersibile contenente un componente di estetrolo
DK3106148T3 (en) 2015-06-18 2018-05-07 Mithra Pharmaceuticals S A Orodispersible dosing unit containing an estetrol component
JP6813150B2 (ja) 2015-06-18 2021-01-13 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロールを含有する口腔内崩壊錠
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
ES2906117T3 (es) * 2017-02-23 2022-04-13 Siemens Healthcare Diagnostics Inc Conjugados de androstenodiona quimioluminiscente
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA712312B (en) * 1970-04-28 1972-01-26 Ochsner Med Found Alton 4,14-estradiene compounds

Also Published As

Publication number Publication date
HUP0201952A2 (en) 2002-10-28
HUP0201952A3 (en) 2003-10-28
SK712002A3 (en) 2002-06-04
AU770412B2 (en) 2004-02-19
JP2003505394A (ja) 2003-02-12
BR0012489A (pt) 2002-04-02
PE20010330A1 (es) 2001-03-22
EP1203011B1 (en) 2004-01-02
TR200200076T2 (tr) 2002-04-22
US6313108B1 (en) 2001-11-06
US6780854B2 (en) 2004-08-24
KR20020092890A (ko) 2002-12-12
US20030087886A1 (en) 2003-05-08
ZA200200106B (en) 2003-06-25
US20020022609A1 (en) 2002-02-21
IL147332A0 (en) 2002-08-14
AR024746A1 (es) 2002-10-23
ES2213596T3 (es) 2004-09-01
NO20020222L (no) 2002-01-25
EP1203011A1 (en) 2002-05-08
CA2379223A1 (en) 2001-01-25
DE60007530D1 (de) 2004-02-05
AU6562900A (en) 2001-02-05
CN1360589A (zh) 2002-07-24
CZ2002192A3 (cs) 2002-06-12
CO5200765A1 (es) 2002-09-27
RU2002103883A (ru) 2004-02-27
HK1043797A1 (zh) 2002-09-27
MXPA02000601A (es) 2002-07-30
US6541465B2 (en) 2003-04-01
WO2001005806A1 (en) 2001-01-25
PL353007A1 (en) 2003-09-22
DE60007530T2 (de) 2004-12-23
TW548277B (en) 2003-08-21
NZ516525A (en) 2003-06-30
ATE257159T1 (de) 2004-01-15

Similar Documents

Publication Publication Date Title
NO20020222D0 (no) Oralt aktive androgener
PT1220856E (pt) Compostos farmaceuticamente activos
IS5568A (is) Lyfjafræðilega virkt morfólínól
DK1181017T3 (da) Metalloproteaseinhibitorer
NO2010019I2 (no) 6-per-deoksy-6-per-(2-karboksetyl)tio-y-cyklodextrin
FI4231U1 (fi) Kotelo
DE60035580D1 (de) Halbleiter
DE60043730D1 (de) Arylsulfonamid-substituierte hydroxamsäure-derivate
DE60032425D1 (de) Ätzvorrichtung
DK1237904T3 (da) 14,15-beta-methylensubstituerede androgener
DE60039349D1 (de) Elektrochemischer kondensator
FI990633L (fi) Pätkätela
DE59902159D1 (de) Aktiver mikromischer
DK1218127T3 (da) Støbevalse
DE60018144D1 (de) Wälzelement
DE60010809D1 (de) Entwicklungsgerät
ITMI991742A0 (it) Bisplatino complessi attivi per via orale
DE50012367D1 (de) Abrollmaschine
ZA200204604B (en) Saccharin derivatives as orally active elastase inhibitors.
ID27139A (id) Bertukol kusmargono
DE60004561D1 (de) Aktive baugruppe
DE60030353D1 (de) Kassette
SE9901854D0 (sv) New pharmaceutically active compounds
IS8740A (is) Lyfjafræðilega virkt morfólínól
SE0000645D0 (sv) New pharmaceutically active compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application